$MNKD after hours Pr $10.00 http://www.mannkin
Post# of 128
Posted On: 06/27/2014 6:36:59 PM
$MNKD after hours Pr $10.00
Website
MannKind Corporation Announces FDA Approval of AFREZZA(R);
A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes
News release
380x253.jpg)
Spotlight
Website
MannKind Corporation Announces FDA Approval of AFREZZA(R);
A Novel, Rapid-Acting Inhaled Insulin for the Treatment of Diabetes
News release
Spotlight
(0)
(0)MannKind Corporation (MNKD) Stock Research Links
Scroll down for more posts ▼